CAS 177325-13-2
:Levofloxacin Hydrochloride
Description:
Levofloxacin Hydrochloride is a synthetic antibiotic belonging to the fluoroquinolone class, primarily used to treat a variety of bacterial infections. It is characterized by its broad-spectrum activity against both Gram-positive and Gram-negative bacteria, making it effective for respiratory tract infections, urinary tract infections, and skin infections. The compound is a chiral molecule, with its levorotatory form being the active isomer, which enhances its antibacterial efficacy compared to its racemic counterpart. Levofloxacin Hydrochloride is typically administered orally or intravenously and is known for its good bioavailability. Its mechanism of action involves inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes crucial for DNA replication and transcription. The substance is generally well-tolerated, although it may cause side effects such as gastrointestinal disturbances, central nervous system effects, and, in rare cases, tendon damage. Due to its potential for developing resistance, it is important to use levofloxacin judiciously and in accordance with susceptibility patterns.
Formula:C18H20FN3O4·HCl
InChI:InChI=1/C18H20FN3O4.ClH/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H/t10-;/m0./s1
InChI key:InChIKey=CAOOISJXWZMLBN-PPHPATTJSA-N
SMILES:O=C1C=2C3=C(C(=C(F)C2)N4CCN(C)CC4)OC[C@H](C)N3C=C1C(O)=O.Cl
Synonyms:- (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride
- (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrochloride (1:1), (3S)-
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, monohydrochloride, (3S)-
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, monohydrochloride, (S)-
- Carboxylic Acid Monohydrochloride
- Levofloxacin Hcl
- LevofloxacinHydrochloride
- Weilisu
- Levofloxacin hydrochloride
- -7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- -9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)
- usp27 99% Levofloxacin white powder Antibacterial
- Levofloxacin white powder Antibacterial
- 3S)-9-Fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid Monohydrochlori
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo-,hydrochloride (1:1), (3S)-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrochloride (1:1), (3S)-
CAS:Formula:C18H21ClFN3O4Purity:98%Color and Shape:SolidMolecular weight:397.8284Levofloxacin hydrochloride
CAS:Formula:C18H20FN3O4·HClPurity:≥ 89.0% (C18H20FN3O4, dried basis)Color and Shape:Off-white to pale beige or light-yellow powderMolecular weight:397.9Levofloxacin Hydrochloride
CAS:<p>Levofloxacin Hydrochloride</p>Purity:99%Molecular weight:397.83g/molLevofloxacin Hydrochloride
CAS:Formula:C18H20FN3O4·HClPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:397.83Levofloxacin hydrochloride
CAS:<p>Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity.</p>Formula:C18H21ClFN3O4Purity:99.78% - 99.98%Color and Shape:SolidMolecular weight:397.8Levofloxacin hydrochloride
CAS:<p>Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, which are enzymes that maintain the integrity of bacterial DNA. It binds to bacterial 16S ribosomal RNA and inhibits protein synthesis, leading to cell death by inhibiting the production of proteins vital for cell division. Levofloxacin has been shown to be effective against many infectious diseases, including urinary tract infections and some types of pneumonia. Levofloxacin also has inhibitory properties against gram-positive bacteria such as Streptococcus pyogenes and Staphylococcus aureus. The mechanism of action is not fully understood, but it is believed that levofloxacin interferes with protein synthesis by binding to the 30S subunit of the bacterial ribosome. The drug also binds to benzalkonium chloride (BAK) in wastewater treatment systems, which may contribute to its effectiveness in these</p>Formula:C18H20FN3O4•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:397.83 g/mol(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
CAS:Formula:C18H21ClFN3O4Purity:98%Color and Shape:Solid, No data available.Molecular weight:397.83Levofloxacin Hydrochloride
CAS:Formula:C18H20FN3O4·(HCl)Color and Shape:White To Light BeigeMolecular weight:361.37 + (36.46)







